KMT2C Loss Promotes NF2‐Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling
Advanced Science · 2026
DOI: 10.1002/advs.202522756 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Liuchao Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, P. R. China. Hauptthemen laut MEDLINE: Meningioma, Neurofibromin 2, Ferroptosis, Meningeal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
High‐grade meningiomas remain clinically challenging due to their aggressive behavior and limited therapeutic options. Although mutations and dysregulation of KMT2 family members have been implicated in various cancers, their functional significance in meningioma remains unclear. While NF2 alterations are the most common drivers of meningioma pathogenesis, the mechanisms regulating NF2 transcription in NF2‐intact tumors are poorly understood. Here, we demonstrate that KMT2C expression is markedly reduced in high‐grade meningiomas and that loss of KMT2C promotes proliferation and invasion in NF2–wild‐type meningioma cells. Mechanistically, KMT2C deficiency suppresses NF2 transcription and inactivates Hippo signaling, leading to enhanced oncogenic activity and increased sensitivity to ferroptosis. Loss of KMT2C impairs the acetyltransferase activity of CBP/EP300, resulting in a global reduction of H3K27ac and transcriptional silencing of NF2. Pharmacological restoration of histone acetylation with the HDAC inhibitor Trichostatin A (TSA) effectively suppressed tumor growth. Collectively, our findings identify KMT2C as a key epigenetic regulator linking promoter histone acetylation, NF2–Hippo pathway activity, and ferroptosis susceptibility. These results provide mechanistic insights into high‐grade meningioma progression and highlight ferroptosis induction and epigenetic modulation as promising therapeutic strategies for NF2–wild‐type, KMT2C‐deficient meningiomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, P. R. China.
- Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, P. R. China.
- Department of Neurosurgery, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, P. R. China.
- Department of Neurosurgery, Northern Jiangsu People's Hospital, Nanjing, P. R. China.
- Department of Neurosurgery, Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, P. R. China.
- Institute For Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, P. R. C…
ORCID-Profile: Jing Ji
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Xinjiang Uygur Autonomous Region Tianshan Innovation Team Plan Item
- China Postdoctoral Science Foundation
- Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University
Zitieren
APA
Zhang, L., Ye, Y., Gu, W., Wang, X., Chen, N., He, Q., Xu, L., Zhao, P., Fu, G., Yuan, G., Shi, W., Chao, H., Tu, Y., & Ji, J. (2026). KMT2C Loss Promotes NF2‐Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling. Advanced Science. https://doi.org/10.1002/advs.202522756
Vancouver
Zhang L, Ye Y, Gu W, Wang X, Chen N, He Q, et al. KMT2C Loss Promotes NF2‐Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling. Advanced Science. 2026. doi:10.1002/advs.202522756
BibTeX
@article{Zhang2026,
author = {Zhang, Liuchao and Ye, Yangfan and Gu, Wei and Wang, Xinyue and Chen, Nuo and He, Qixin and Xu, Lei and Zhao, Pengzhan and Fu, Guoqiang and Yuan, Guangyao and Shi, Wenqian and Chao, Honglu and Tu, Yiming and Ji, Jing},
title = {KMT2C Loss Promotes NF2‐Wildtype Meningioma Progression and Ferroptosis Sensitivity via Epigenetic Repression of Hippo Signaling},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202522756}
}
EUVIMED